Pharming Group (PHAR) Short Interest Ratio & Short Volume → Wall Street legend who predicted 2021 tech crash issues new warning (From Chaikin Analytics) (Ad) Free PHAR Stock Alerts $9.59 -0.04 (-0.42%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Pharming Group Short Interest DataCurrent Short Volume3,900 sharesPrevious Short Volume1,300 sharesChange Vs. Previous Month+200.00%Dollar Volume Sold Short$36,621.00Short Interest Ratio / Days to Cover1.4Last Record DateApril 30, 2024Outstanding Shares67,340,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume1,816 sharesAverage Trading Volume2,481 sharesToday's Volume Vs. Average73% Short Selling Pharming Group ? Sign up to receive the latest short interest report for Pharming Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPHAR Short Interest Over TimePHAR Days to Cover Over TimePHAR Percentage of Float Shorted Over Time Ad Manward PressThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company Pharming Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,900 shares $36,621.00 +200.0%N/A1.4 $9.39 4/15/20241,300 shares $13,273.00 -13.3%N/A0.5 $10.21 3/31/20241,500 shares $16,260.00 -44.4%N/A0.6 $10.84 3/15/20242,700 shares $30,996.00 -10.0%N/A1.2 $11.48 2/29/20243,000 shares $34,350.00 +900.0%N/A1.3 $11.45 2/15/2024300 shares $3,315.00 -72.7%N/A0.2 $11.05 Get the Latest News and Ratings for PHAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,100 shares $14,025.00 +57.1%N/A0.7 $12.75 1/15/2024700 shares $9,030.00 -30.0%N/A0.3 $12.90 12/31/20231,000 shares $11,430.00 +100.0%N/A0.4 $11.43 12/15/2023500 shares $5,900.00 -16.7%N/A0.2 $11.80 11/30/2023600 shares $6,738.00 +500.0%N/A0.2 $11.23 11/15/2023100 shares $1,147.00 -80.0%N/A0 $11.47 10/31/2023500 shares $5,800.00 -44.4%N/A0.1 $11.60 10/15/2023900 shares $10,800.00 -91.6%N/A0.3 $12.00 9/30/202310,700 shares $121,980.00 +269.0%N/A3.1 $11.40 9/15/20232,900 shares $39,150.00 +7.4%N/A1 $13.50 8/31/20232,700 shares $34,006.50 +68.8%N/A1.3 $12.60 8/15/20231,600 shares $19,206.72 +33.3%N/A0.7 $12.00 7/31/20231,200 shares $14,400.00 +300.0%N/A0.5 $12.00 7/15/2023300 shares $3,660.00 -76.9%N/A0.1 $12.20 6/30/20231,300 shares $15,145.00 -60.6%N/A0.3 $11.65 6/15/20233,300 shares $40,623.00 +17.9%N/A0.1 $12.31 5/31/20232,800 shares $33,600.00 +180.0%N/A0.1 $12.00 5/15/20231,000 shares $11,610.00 -37.5%N/A0 $11.61 4/30/20231,600 shares $17,792.00 -68.6%N/A0.1 $11.12 4/15/20235,100 shares $58,318.50 -68.5%N/A0.2 $11.44 3/31/202316,200 shares $218,700.00 +1,700.0%N/A0.7 $13.50 3/15/2023900 shares $10,971.00 -55.0%N/A0.1 $12.19 2/28/20232,000 shares $24,440.00 -33.3%N/A0.5 $12.22 2/15/20233,000 shares $39,390.00 +500.0%N/A0.6 $13.13 1/31/2023500 shares $6,685.00 +150.0%N/A0.1 $13.37 1/15/2023200 shares $2,688.00 -85.7%N/A0 $13.44 12/30/20221,400 shares $15,442.00 -60.0%N/A0.2 $11.03 12/15/20223,500 shares $39,725.00 +52.2%N/A0.5 $11.35 11/30/20222,300 shares $28,658.00 No ChangeN/A0.3 $12.46 11/15/20222,300 shares $26,887.00 -11.5%N/A0.3 $11.69 10/31/20222,600 shares $25,194.00 -45.8%N/A0.4 $9.69 10/15/20224,800 shares $44,400.00 +182.4%N/A0.9 $9.25 9/30/20221,700 shares $16,728.00 -62.2%N/A0.3 $9.84 9/15/20224,500 shares $52,650.00 -56.7%N/A1.6 $11.70This unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company PHAR Short Interest - Frequently Asked Questions What is Pharming Group's current short interest? Short interest is the volume of Pharming Group shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,900 shares of PHAR short. Learn More on Pharming Group's current short interest. What is a good short interest ratio for Pharming Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHAR shares currently have a short interest ratio of 1.0. Learn More on Pharming Group's short interest ratio. Is Pharming Group's short interest increasing or decreasing? Pharming Group saw a increase in short interest in April. As of April 30th, there was short interest totaling 3,900 shares, an increase of 200.0% from the previous total of 1,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pharming Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pharming Group: Lyell Immunopharma, Inc. (16.91%), ORIC Pharmaceuticals, Inc. (15.19%), Olema Pharmaceuticals, Inc. (15.02%), GH Research PLC (5.05%), Silence Therapeutics plc (0.99%), Stoke Therapeutics, Inc. (15.94%), CureVac (4.79%), Calliditas Therapeutics AB (publ) (0.03%), Phibro Animal Health Co. (2.76%), Phathom Pharmaceuticals, Inc. (41.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Pharming Group stock? Short selling PHAR is an investing strategy that aims to generate trading profit from Pharming Group as its price is falling. PHAR shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharming Group? A short squeeze for Pharming Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PHAR, which in turn drives the price of the stock up even further. How often is Pharming Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHAR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Lyell Immunopharma Short Squeeze ORIC Pharmaceuticals Short Squeeze Olema Pharmaceuticals Short Squeeze GH Research Short Squeeze Silence Therapeutics Short Squeeze Stoke Therapeutics Short Squeeze CureVac Short Squeeze Calliditas Therapeutics AB (publ) Short Squeeze Phibro Animal Health Short Squeeze Phathom Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PHAR) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsDems have chosen Biden replacement?Paradigm Press